These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 16184031

  • 41. In-vitro and in-vivo pharmacokinetic interactions of amprenavir, an HIV protease inhibitor, with other current HIV protease inhibitors in rats.
    Shibata N, Gao W, Okamoto H, Kishida T, Yoshikawa Y, Takada K.
    J Pharm Pharmacol; 2002 Feb; 54(2):221-9. PubMed ID: 11848286
    [Abstract] [Full Text] [Related]

  • 42. Differential effect of HIV-1 protease inhibitors on P-glycoprotein function in multidrug-resistant variants of the human CD4+ T lymphoblastoid CEM cell line.
    Dupuis ML, Tombesi M, Sabatini M, Cianfriglia M.
    Chemotherapy; 2003 May; 49(1-2):8-16. PubMed ID: 12714803
    [Abstract] [Full Text] [Related]

  • 43. Variation in oral clearance of saquinavir is predicted by CYP3A5*1 genotype but not by enterocyte content of cytochrome P450 3A5.
    Mouly SJ, Matheny C, Paine MF, Smith G, Lamba J, Lamba V, Pusek SN, Schuetz EG, Stewart PW, Watkins PB.
    Clin Pharmacol Ther; 2005 Dec; 78(6):605-18. PubMed ID: 16338276
    [Abstract] [Full Text] [Related]

  • 44. Evidence of P-glycoprotein mediated apical to basolateral transport of flunisolide in human broncho-tracheal epithelial cells (Calu-3).
    Florea BI, van der Sandt IC, Schrier SM, Kooiman K, Deryckere K, de Boer AG, Junginger HE, Borchard G.
    Br J Pharmacol; 2001 Dec; 134(7):1555-63. PubMed ID: 11724763
    [Abstract] [Full Text] [Related]

  • 45. Differences in the intracellular accumulation of HIV protease inhibitors in vitro and the effect of active transport.
    Jones K, Hoggard PG, Sales SD, Khoo S, Davey R, Back DJ.
    AIDS; 2001 Apr 13; 15(6):675-81. PubMed ID: 11371681
    [Abstract] [Full Text] [Related]

  • 46. P-glycoprotein expression in HTLV-III cells after treatment with HIV-1 protease inhibitors.
    Sánchez Mdel C, López P, Vélez R, Yamamura Y.
    Ethn Dis; 2008 Apr 13; 18(2 Suppl 2):S2-60-4. PubMed ID: 18646322
    [Abstract] [Full Text] [Related]

  • 47. HIV protease inhibitors: garlic supplements and first-pass intestinal metabolism impact on the therapeutic efficacy.
    Berginc K, Trdan T, Trontelj J, Kristl A.
    Biopharm Drug Dispos; 2010 Nov 13; 31(8-9):495-505. PubMed ID: 21104925
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Saquinavir, an HIV protease inhibitor, is transported by P-glycoprotein.
    Kim AE, Dintaman JM, Waddell DS, Silverman JA.
    J Pharmacol Exp Ther; 1998 Sep 13; 286(3):1439-45. PubMed ID: 9732409
    [Abstract] [Full Text] [Related]

  • 50. Human immunodeficiency virus protease inhibitors serve as substrates for multidrug transporter proteins MDR1 and MRP1 but retain antiviral efficacy in cell lines expressing these transporters.
    Srinivas RV, Middlemas D, Flynn P, Fridland A.
    Antimicrob Agents Chemother; 1998 Dec 13; 42(12):3157-62. PubMed ID: 9835508
    [Abstract] [Full Text] [Related]

  • 51. Inhibition of placental P-glycoprotein: impact on indinavir transfer to the foetus.
    Sudhakaran S, Rayner CR, Li J, Kong DC, Gude NM, Nation RL.
    Br J Clin Pharmacol; 2008 May 13; 65(5):667-73. PubMed ID: 18093255
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Effect of saquinavir/ritonavir on P-glycoprotein activity in healthy volunteers using digoxin as a probe.
    Schmitt C, Kaeser B, Riek M, Bech N, Kreuzer C.
    Int J Clin Pharmacol Ther; 2010 Mar 13; 48(3):192-9. PubMed ID: 20197013
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Transepithelial transport of prodrugs of the HIV protease inhibitors saquinavir, indinavir, and nelfinavir across Caco-2 cell monolayers.
    Rouquayrol M, Gaucher B, Roche D, Greiner J, Vierling P.
    Pharm Res; 2002 Nov 13; 19(11):1704-12. PubMed ID: 12458677
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.